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Recent experiments in these laboratories  a have shown that penicillin strik- 
ingly inhibits the growth of murine typhus rickettsiae in the  yolk sac  of  the 
developing hen's egg.  We have also described  ~,: uniformly fatal murine typhus 
infection in brown mice of the dba strain.  With the thought that therapeutic 
agents are most satisfactorily tested in experimental animals under conditions 
which produce fatal  infection in  the  controls,  we have  utilized  dba  mice in 
our first tests of penicillin in murine typhus. 
Material  and  Methods 
The strain of murine typhus used had been carried in the yolk sac for eleven genera- 
tions.  Its virulence for mice and guinea pigs did not change during this period.  The 
virulence of the strain for man was accidentally established by the occurrence of typhus 
fever in one of us during the course of these experiments.  (This illness occurred in 
spite of the administration  2 months previously of an approved epidemic typhus yolk 
sac vaccine.  The course of the disease was probably modified by the vaccination, 
since the only neurological manifestation  was severe headache.  Fever lasted  for 2 
weeks, and mild rash developed on the 7th day.) 
Mice were infected in groups of 10 to 14, by the intraperitoneal  injection of rickett- 
sial doses of variable size, ranging from overwhelming doses to doses approaching the 
minimum necessary for uniformly fatal infection.  Some experiments were conducted 
in an environmental  temperature of 65-72°F., while others were carried out in a room 
with a temperature range of 75-80°F.  The materials used for inoculation and the en- 
vironmental  temperatures  were chosen in the light  of information  gained from pre- 
vious  work,  s' : as a  result  of  which  we were  able  to predict  quite  accurately the 
incubation  period and course of the infection in the controls in each experiment. 
Half of the mice in each group were treated with penicillin.  Variations in the time 
of initiating  treatment, the daily dosage, and the route of injection  of the drug are 
indicated  in Tables  I  to VI.  Treatment was continued  until  death of  the treated 
animals, or, in case of survival, until about 24 hours after the death of the last control 
1Greiff, D., and Pinkerton, H., Proc. Soc. Exp. Biol.  and Med., in press. 
: Moragues, V., and Pinkerton,  H., J. Exp. Med., 1944, "/9, 35. 
8Moragues, V., and Pinkerton, H., J. Exp. Med.,  1944, 79, 41. 
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TABLE  I 
Effect of Penicillin on Murine Typhus in Mice, Experiment I 
Overwkdming Dosage of Rickettsiae (Yolk Sac Suspension) lntraperitoneally 
Room temperature 75-80°F. 
Mouse 
No. 
I  C1 
I C2 
I Ca 
I C4 
I C5 
I  C6 
I  Px 
I  P~ 
iP, 
IP4 
I  P5 
I  Pe 
Treatment begun 
Control 
Control 
Control 
Control 
Control 
Control 
30 hrs. after in- 
jection 
Dosage of penicillin 
640 units  per day sub- 
cutaneously  in  di- 
vided  doses  at  6 a.m. 
I0 a.m.,  1  p.m.,  5 
p.m.,  9 p.m.,  and 12 
mid. 
Illness  Survival 
began  period 
days  days 
3  3½ 
3  4 
3  3½ 
3  4 
3  4 
3  4 
3  4 
s  s½ 
3  S½ 
3  3½ 
3  4 
3  4i 
Remarks 
No  apparent 
effect from 
treatment 
TABLE II 
Effect of Penicillin  on Murine Typhus in Mice, Experiment II 
Heavy Dosage of Rickettsiae (Mouse Spleen Suspension) Intraperitoneally 
Room temperature 65-72°F. 
Mous~ 
No. 
II C, 
II Cs 
II (]8 
II C4 
II C5 
II PI 
II P2 
II P8 
II Pt 
II  P5 
Treatment 
begun 
Control 
Control 
Control 
Control 
Control 
Dosage of penicillin 
3½ hrs. after 
injection 
doy~ 
3 
S.C.*  864 units per day 
in divided doses I  S.C. 
at 9 a.m., 12 m.,[  I.P.* 
3 p.m.,  fi p.m.,  I.P. 
and 9 p.m.  I.P. 
lness  Surviv 
a  perlo, 
~  days 
3½ 
4  4[ 
4  4[ 
4½  s½ 
4½  s~ 
5  6~ 
4  4½ 
s~  6~ 
s~  6½ 
5  6i 
Remarks 
Definite  prolonga- 
tion  of  incuba- 
tion and survival 
periods 
* S.C. means subcutaneous;  I.P. means intraperitoneal. 
animal in the series.  All penicillin injections were given under ether anesthesia, in 
order to minimize trauma. 
Necropsy was  done and  Giemsa-stained smears were  made from the  peritoneal 
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TABLE III 
Effect of Penicillin on Murine Typhus in Mice, Experiment III 
Heavy Dosage of Rickettsiae (Mouse Spleen Suspension) Intraperitoneally 
Room temperature  75-80°F. 
Mouse  No. 
III Cx 
III C2 
iii c8 
III C4 
III C5 
III C6 
III Px 
III P2 
III P3 
III P4 
III P5 
III P6 
Treatment begun 
Control 
Control 
Control 
Control 
Control 
Control 
6  hrs. after in- 
jection 
Dosage of penicillin 
1100 units per day 
in divided doses 
at  9  a.m.,  11 
a.m.,  1  p.m.,  4 
p.m., 7 p.m., 10 
p.m.,  and  12 
mid. 
Route 
I.P. 
I.P. 
I.P. 
I.P. 
I.P. 
I.P. 
Illness  Survival 
began  period 
days  days 
41  4~ 
4½  52 
s  s½ 
4½  s~ 
4½  5½ 
5  Sl 
S½  6 
s½  s½ 
6  61 
s~ 
s] 
6 
Remarks 
Traumatic 
death? 
Survived 
Survived 
Survived 
TABLE IV 
Effect of Penicillin on M~rine Typhus in Mice, Exper~enJ IV 
Moderate Dosage  of Rickettsiae (Mouse Brain Suspension) Intraperiloneally 
Room temperature 65-720F. 
Mouse No. 
IV C1 
IV C2 
1vc8 
IV C4 
IV C5 
IV Ce 
IV P1 
IV P2 
IV 1"8 
IV P4 
IV P~ 
IV Ps 
Treatment 
begun 
Control 
Control 
Control 
Control 
Control 
Control 
24 hrs. after 
injection 
Dosage of penicillin 
830 units per day 
in divided doses 
at 9 a.m., 12 m., 
3 p.m.,  6 p.m., 
and 9 p.m. 
Route 
S.C. 
S.C. 
S.C. 
I.P. 
I.P. 
I.P. 
Illness 
began 
days 
5 
si 
6t 
s½ 
s 
si 
6t 
6½ 
6 
7 
7 
7 
Survival 
period 
days 
6 
6 
7 
7 
6[ 
61 
7t 
7i 
6~ 
7½ 
Remarks 
Survived 
Survived 
(Table VI).  In about half of the animals dying, cultures were made on blood agar 
from heart's blood and spleen.  In 4 mice, cultures were made also from lung tissue. 
Histological sections, including  Giemsa stains, were made of the hearts, lungs, spleens, 
livers, kidneys, and brains of 8 animals. 434  PENICILLIN  IN  MURINE  TYPHUS  INFECTION 
TABLE  V 
Effect of Penicillin on Murine Typhus in Mice, Experiment  V 
Moderate Dosate (Mouse Brain Intraperitoneally)  Approaching the Minimal Lethal Dosage 
Room temperature 65-72°F. 
Mouse  No. 
V Ct 
V C2 
V C3 
V C4 
V C5 
V  C6 
V P1 
V  P2 
VP8 
VP4 
V P5 
V Ps 
Treatment 
begun 
Control 
Control 
Control 
Control 
Control 
Control 
7 hrs. after 
injection 
Dosage of penicillin 
930 units per day 
in divided doses 
at  9  a.m.,  11 
a.m.,  1  p.m.,  4 
p.m., 7  p.m.,  9 
p.m.,  and  12 
mid. 
Route 
I.P° 
I.P. 
I.P. 
I.P. 
I.P. 
I.P. 
Illness began 
days 
7 
6½ 
6½ 
6½ 
7 
6½ 
No illness 
No illness 
No illness 
No illness 
No illness 
No illness 
Survival 
period 
days 
8 
7 
7 
71 
7½ 
7½ 
Rema~s 
Survived 
Survived 
Survived 
Survived 
Survived 
Survived 
TABLE  VI 
F~ffed of Penicillin on Murine Typhus in Mice, Experiment  VI 
Moderate Dosage (Mouse Brain lntraperitoneally)  Apparently Just bdow the 
Minimal Lethal Dosage 
Room temperature 65-72°F. 
~ouse No. 
VI El 
VI C2 
VI Ca 
VI C4 
VI C5 
VI C6 
VI Cv 
VI P1 
VI P2 
VI P8 
VI P4 
VI Ps 
VI Ps 
VI P7 
Treatment 
begun 
Control 
Control 
Control 
Control 
Control 
Control 
Control 
48 hrs. after 
injection 
Dosage of penicillin 
640 units per day 
in divided doses 
at 9 a.m., 12 m., 
3  p.m.,  6  p.m., 
and 9 p.m. 
Route  Illness i  Degree of 
began  illness 
days 
7  Severe 
7~  Severe 
7  Severe 
7~  Severe 
8½  Severe 
7~  Severe 
7  Severe 
Survival 
period 
days 
8 
7t 
8½ 
9 
8 
8t 
Remarks 
Survived 
Aborted 
Killed 
Survived 
Survived 
Survived 
Survived 
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The penicillin was furnished by Pfizer and Company, through the courtesy of the 
Committee on Therapeutic Agents of the National Research Council. 
RESULTS 
The results are shown in Tables I to VI.  In Experiment I, where overwhelm- 
ing doses of rickettsiae were given and  treatment started 30 hours later,  no 
therapeutic effect is apparent.  In Experiment II, definite lengthening of the 
incubation  period  and  survival  time  is  apparent. 
In Experiments III and IV, a  survival rate of approximately 50 per cent is 
seen in the treated animals, while all of the controls died, as anticipated on the 
basis  of previous  observations.  2. 3 
In Experiment V, where the prolonged incubation period indicated that the 
dosage  of rickettsiae was near the ~.L.D.  and  treatment was begun  7  hours 
after injection,  no  illness occurred  in  the  treated animals,  while  all controls 
clied,  as expected. 
In Experiment VI, one moderately ill  treated animal was sacrificed on the 
8th  day for information,  and  another  treated animal died  on  the  10th  day, 
apparently as a  result of extensive postpartum hemorrhage, so that no death 
in the treated animals was definitely attributable to typhus.  Treatment was 
not started in this series until 48 hours after injection with rickettsiae.  The 
greatly prolonged  incubation  period  and  the  survival of one  control  in  this 
series indicate that the dosage may have been just below the ~J..D., although 
in previous comparable series we had found  100 per cent mortality. 
Pathological and  Bacteriological Studies.--A  crucial  point  in  these  experi- 
ments was the determination of the presence or absence of secondary bacterial 
infection. 
No illness or death occurred in our stock mice during the course of these  experi- 
ments.  Necropsies of all mice dying after the injection of rickettsiae (with the excep- 
tion of mouse III P~, Experiment III, in which hemoperitoueum was present) showed 
mucinous peritonitis.  In every instance, including  the treated mouse killed  for in- 
formation, rickettsiae were present in relatively large numbers, both free and within 
mesotheli&l cells and neutrophiles in the peritoneal exudate.  No evidence of secondary 
bacterial infection was seen in the peritoneal smears of any of the mice. 
The only gross finding  other than the peritonitis was red consolidation  of one or 
more lobes of the lungs.  This observation was made in 8 of the 36 control mice and 
in 2 of the treated mice.  In most instances,  this condition was found in mice which 
had been moribund for 8 to 20 hours before death.  Histological study of the lungs 
from these animals showed intense congestion  and edema, with hemorrhage into the 
alveoli, and some increase in neutrophiles in the alveolar walls.  The picture did not 
resemble that of a bacterial pneumonia. 
Giemsa-stained sections showed no organisms in the lungs of these animals, except 
for an occasional  group of rickettsiae in cells of the alveolar walls,  and in pleural 
mesothelial cells.  In three of the four instances in which such lung tissue was cultured 436  PENICILLIN IN M'URINE TYPHUS IN]PECTION 
on blood agar, no growth occurred.  In the fourth case, a large bacillus, probably a 
contaminant, was recovered. 
As a result of these studies,  the conclusion was drawn that the pulmonary lesion 
seen in some of the mice was not a bacterial pneumonia.  It may have been a rickettsial 
pneumonia, or simple terminal edema and congestion in moribund animals.  A point 
of importance was the fact that in Experiment V, where none of the treated mice 
showed illness, none of the controls showed the pulmonary lesion. 
Cultures from the heart's blood and spleen of the control animals were uniformly 
sterile.  Sections of the kidneys, spleens, livers, and brains of the dead mice showed 
no pathological lesions.  Sections of heart showed a myocarditis similar to that seen 
in typhus infection in man. 
Interpretation 
On the whole it was concluded that secondary bacterial infection was not 
present in our mice, and that the effect observed was due to the action of peni- 
cillin on the rickettsiae.  This interpretation is in harmony with the previously 
described inhibitory action of penicillin on rickettsial growth in the yolk sac. 
It is possible that the action of penicillin on rickettsiae may be exerted only 
on those organisms which are in the process of passing from one cell to another, 
but it seems more probable that  penicillin affects the  growth  of rickettsiae 
within  cells. 
Although most of the favorable therapeutic results were obtained by the 
intraperitoneal injection of penicillin following the intraperitoneal injection of 
rickettsiae, there is some evidence, particularly in Experiment VI,  that sub- 
cutaneous injection of  the  drug  was  effective.  It  should be noted  that  in 
most of the experiments there was  a  daily period of 9  hours  during which 
the penicillin concentration of the drug was probably not maintained at effective 
levels. 
The results obtained are  of theoretical as well as practical interest.  As- 
suming  that  penicillin,  like  the  sulfa  drugs,  exerts  its  bacteriostatic  action 
by interfering with metabolic activity, the apparent vulnerability of rickettsiae 
to penicillin suggests that they possess enzyme systems which enable them to 
carry on a  certain amount of independent metabolic activity. 
Obviously no prediction can be made  from these experiments concerning 
the effect of penicillin on human typhus infection.  Since the human disease 
is caused by the growth of rickettsiae in vascular endothelium, however, intra- 
venous injection of penicillin would bring the  drug into direct contact with 
the cells containing the organisms.  If sufficiently high concentration of the 
drug can be established in the blood Stream in the early stages of the disease, 
it would seem reasonable to expect a beneficial therapeutic effect.  The results 
would seem to justify a  thorough clinical trial of penicillin in human typhus. 
They suggest that treatment in  the early stages of illness may be important, 
and that the duration and intensity of treatment should be somewhat increased 
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SUMMARY 
The administration of penicillin in relatively large but non-toxic doses to 
dba mice after injection with murine typhus rickettsiae resulted in a  marked 
reduction in mortality, particularly when the initial dosage of rickettsiae was 
relatively small, approaching the minimal lethal dose.  No evidence of second- 
ary bacterial infection was obtained by bacteriological and histological studies, 
and it seems justifiable to conclude that the greatly increased survival rate in 
the treated mice was caused by the action of penicillin on typhus rickettsiae. 
The  theoretical and practical implications of the results are  discussed. 